An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies
Description
Over the last three years, after the outbreak of the COVID-19 pandemic, an unprecedented number of novel diagnostic tests have been developed. Assays to evaluate the immune response to SARS-CoV-2 have been widely considered as part of the control